Italian MPN patients share their stories in landmark Quality-of-Life study
NCT ID NCT04378855
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is collecting information on quality of life and symptoms from 572 Italian patients with certain types of blood cancers called myeloproliferative neoplasms (MPNs). Participants fill out questionnaires about how their disease and treatments affect their daily functioning and well-being. The goal is to build a platform to better understand patient experiences, not to test a new drug or therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how myeloproliferative neoplasms affect patients' daily lives and well-being.
- What could go wrong
- This is an observational study, so it does not test any new treatment. Results may not lead to direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
.C.D.U. Ematologia - Università del Piemonte Orientale Amedeo Avogadro
Novara, Italy
-
Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo
Cagliari, Italy
-
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia
Alessandria, Italy
-
Aou Careggi - Firenze - Sod Ematologia
Florence, Italy
-
Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino
Torino, Italy
-
Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto
Bari, Italy
-
Aou Di Modena - Sc Ematologia
Modena, Italy
-
Aou Di Sassari - Cliniche Universitarie - Stabilimento Cliniche Di San Pietro - Uoc Ematologia
Sassari, Italy
-
Aou Federico Ii - Napoli - Uoc Ematologia
Naples, Italy
-
Aou Pisana - Uo Ematologia Universitaria
Pisa, Italy
-
Aou Policlinico P. Giaccone - Palermo - Uo Ematologia
Palermo, Italy
-
Asl Di Asti, Ospedali Riuniti - Presidio Ospedaliero Cardinal G. Massaia - Sc Oncologia
Asti, Italy
-
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia
Roma, Italy
-
Asl to 2, Torino Nord Emergenza San Giovanni Bosco - Ssd Ematologia
Torino, Italy
-
Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia
Rimini, Italy
-
Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia
Reggio Emilia, Italy
-
Azienda Ospedaliera "S.Gerardo"
Monza, Italy
-
C.R.O.B. - I.R.C.C.S. - Rionero in Volture - Uoc Ematologia
Rionero in Vulture, Italy
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano
Milan, Italy
-
Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia
Pavia, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica
Roma, Italy
-
Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia
Bari, Italy
-
Istituto di Ematologia "Lorenzo e A. Seragnoli"
Bologna, Italy
-
Ospedale Mauriziano Umberto I - Torino - Scdu Ematologia
Torino, Italy
-
Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia
Roma, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a new drug help when standard treatment fails for polycythemia vera?
- Can a modified interferon rein in early myelofibrosis?
- Can a biologic drug outperform standard therapy for a rare blood cancer?
- Can pressurized oxygen boost cord blood transplants?
- Can a drug free myelofibrosis patients from frequent blood transfusions?